Acerca de ALK
Líder mundial en inmunoterapia de alergias.
ALK es una compañía farmacéutica internacional especializada en la investigación de la prevención, el diagnóstico y el tratamiento de la alergia.
Referencias bibliográficas
Bufe A, Eberle P, Franke-Beckmann E, et al. Safety and efficacy in children of an SQ-standardized grass allergen tablet for sublingual immunotherapy. J Allergy Clin Immunol 2009;123:167-73.
Lamb CE, Ratner PH, Johnson CE, et al. Economic impact of workplace productivity losses due to allergic rhinitis compared with select medical conditions in the United States from an employer perspective. Curr Med Res Opin. 2006;22:1203-10.
Meltzer EO, Gross GN, Katial R, et al. Allergic rhinitis substantially impacts patient quality of life: findings from the Nasal Allergy Survey Assessing Limitations. J Fam Pract. 2012;61(2):S5-10.
Last updated: 2016.11.16